1 Jul 2019

List of USFDA approved Biosimilar [till date]

Posted Byadmin

Comments0

Click here to view the list.

USFDA approved Biosimilars

US approval	Year of Approval	Biosilimar Brand	Company	Biomolecule	Reference Product
1	2015	Zarxio	Amgen	Filgrastim	Neupogen
2	2016	Inflectra	Janssen Biotech	Infliximab	Remicade
3	2016	Erelzi	Amgen	Etanercept	Enbrel
4	2016	Amjevita	AbbVie	Adalimumab	Humira
5	2017	Renflexis	Amgen	Infliximab	Remicade
6	2017	Cyltezo	AbbVie	Adalimumab	Humira
7	2017	Mvasi	Roche	Bevacizumab	Avastin
8	2017	Ogivri	Roche	Trastuzumab	Herceptin
9	2017	Ixifi	Amgen	Infliximab	Remicade
10	2018	Retacrit	Amgen (Epogen) / Procrit (Janssen Biotech)	Epoetin alfa	Epogen/Procrit
11	2018	Fulphila	Amgen	Pegfilgrastim	Neulasta
12	2018	Nivestym	Amgen	Filgrastim	Neupogen
13	2018	Hyrimoz	AbbVie	Adalimumab	Humira
14	2018	Udenyca	Amgen	Pegfilgrastim	Neulasta
15	2018	Truxima	Roche	Rituximab	Rituxan
16	2018	Herzuma	Roche	Trastuzumab	Herceptin
17	2019	Ontruzant	Roche	Trastuzumab	Herceptin
18	2019	Trazimera	Roche	Trastuzumab	Herceptin
19	2019	Eticovo	Amgen	Etanercept	Enbrel
20	2019	Kanjinti	Roche	trastuzumab	Herceptin
21	2019	Pfizer	Roche	Bevacizumab	Avastin
US approval	Year of Approval	Biosilimar Brand	Company	Biomolecule	Reference Product